Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Yes—but only as an investigational technology. MIT and Brigham and Women’s Hospital have reported an under-the-skin prototype that detects the physiological pattern of a fentanyl overdose and pumps naloxone automatically. It has reversed overdoses in animal studies, not in a completed human trial, and it is not available to buy or request as a treatment. For people who need a product today, FDA-authorized nonprescription naloxone nasal spray remains the practical option.
What the implant is—and what it is not
The headline refers to a closed-loop biomedical implant developed by MIT and Brigham and Women’s Hospital. The prototype is placed under the skin and is roughly the size of a stick of gum. It combines vital-sign sensors, an onboard decision algorithm and a micropump containing naloxone.
It is an investigational prototype, not an approved medical device. No completed human trial, FDA approval, commercial launch date, price, implant duration or replacement schedule has been established for it. Researchers have identified miniaturization, battery life and the best implantation site as continuing engineering problems.
“This could really address a significant unmet need in the population that suffers from substance abuse and opiate dependency,” said Giovanni Traverso, an MIT associate professor and Brigham and Women’s Hospital gastroenterologist, describing the intended focus on people at high risk.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.#1 Best Overall
Padagis Naloxone HCI Nasal Spray, 4 mg – Emergency Treatment for Opioid Overdose - Rapid-Response Opioid Overdose Reversal, 2 Dose Single Use Nasal Spray
- QUICK & EFFECTIVE: Padagis Naloxone HCl Nasal Spray delivers a dose of naloxone, designed to provide quick and effective reversal of opioid overdose symptoms.
- SIMPLE TO USE: With a simple nasal spray mechanism, Padagis Naloxone HCI Nasal Spray is user-friendly, allowing for ease of use in emergency situations. Safe to use even when Opioids aren’t present.
- COMPACT & CONVENIENT: Each packet contains a nasal spray device and can be easily carried in pockets, purses, or emergency kits, ensuring life-saving intervention is always within reach.
- TRUSTED BY PROFESSIONALS: By equipping individuals with the means to respond to opioid overdoses, Padagis Naloxone HCI Nasal Spray empowers communities to help save lives, offering support in critical moments. Naloxone is trusted by first responders.
What it measures
The MIT system monitors heart rate, breathing rate, blood pressure and oxygen saturation. Using several signals rather than breathing alone is intended to help distinguish opioid-induced respiratory depression from other causes of slow or stopped breathing, such as sleep apnea.
What it delivers
The reservoir can hold up to 10 milligrams of naloxone. When the algorithm identifies the overdose pattern, the micropump is designed to release the drug in about 10 seconds. MIT and Brigham and Women’s Hospital reported reversal in 96 percent of overdose experiments in animals in 2024. That percentage is an animal-study result; it is not a human success rate.
Rank #2
- Original Prescription Strength: Two 4 mg single-dose devices. Available over the counter without a prescription. Works quickly, reversing an opioid overdose in minutes.
- A Staple For Medical Supplies & Equipment: NARCAN Nasal Spray is an addition to any emergency first aid kit. It's designed for opioid emergencies and can help save a life in case of an opioid overdose.
- Used by First Responders: Naloxone nasal spray is carried by first responders and commonly employed in emergency situations. NARCAN Nasal Spray is designed to rapidly reverse the effects of a life-threatening opioid overdose. Use as directed.
- Easy to Use: Easy to use nasal spray opioid overdose treatment. No nasal swabs or injections are needed. Safe to use even if opioids are not present.
- First Aid Kit Item: this naloxone overdose medicine can help complete your first aid kit. Designed to rapidly reverse the effects of opioid overdose No training required.
How automatic detection and reversal work
- Opioids suppress breathing. A dangerous overdose can progress from slow or stopped breathing to oxygen deprivation and death.
- Sensors watch for the pattern. The implant combines respiratory and cardiovascular measurements, rather than relying on one threshold.
- An algorithm decides whether the pattern is consistent with overdose. The goal is to trigger early while limiting unnecessary doses for unrelated breathing interruptions.
- The pump administers naloxone. Naloxone is an opioid antagonist: it displaces opioids from receptors and can restore breathing.
- Emergency care is still required. Naloxone’s effect is temporary, and the implant does not remove opioids from the body. Anyone responding to a suspected overdose should contact emergency services and follow the instructions on an approved naloxone product.
The prototype’s multisensor approach may reduce false alarms, but the available reports do not provide a human false-positive rate or show how it performs during unsupervised everyday use.
A related implant: the Naloximeter
Researchers at Washington University and Northwestern University have described the Naloximeter, a separate implantable platform. It combines optical sensors, naloxone delivery and communications so it can detect respiratory depression, administer naloxone and alert first responders.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Rank #3
- Used by first responders
- Original prescription strength
- Safe and easy to use
- Designed to rapidly reverse the effects of an opioid emergency
The Naloximeter has rescued animals in both small- and large-animal studies. The publication presents it as clinically translatable work, not as an approved commercial implant. Human performance, consumer availability, battery life, reservoir replacement and implant longevity are not established.
Has an implant been tested in people?
No source establishes a completed human trial of either the MIT implant or the Naloximeter. A University of Washington project provides human feasibility context, but it used a wearable injector rather than an implanted device.
Rank #4
- Full prescription strength: Nasonex 24HR provides effective allergy relief with mometasone furoate (glucocorticoid) 50 mcg per spray; available over the counter, without a prescription
- 24-hour relief: This nasal spray temporarily relieves allergy symptoms including nasal congestion, runny nose, sneezing, and itchy nose caused by hay fever or other upper respiratory allergies
- Non-drowsy, scent-free mist: Multi-symptom allergy and congestion relief nasal spray without the drowsiness, so your day stays on track
- How Nasonex works: A trusted choice designed for targeted multi-symptom control; You may start to feel relief within 12 hours and full effect after several days of regular, once-a-day use
- Dosing: Adults 12+: 2 sprays per nostril once daily; Children 2-11: 1 spray per nostril once daily (adult supervision required); Do not use under age 2; See package insert for full directions
What the University of Washington wearable study did
- In Vancouver, 25 participants with opioid-use disorder supplied real-world breathing data for algorithm development. The wearable did not inject naloxone in that setting.
- In a separate hospital study, 20 healthy volunteers held their breath for 15 seconds to simulate apnea, and the wearable injected naloxone.
- The investigators said longer unsupervised studies and testing in people using opioids nonmedically were still needed.
“We have created algorithms that run on a wearable injector to detect when the wearer stops breathing and automatically inject naloxone,” said Justin Chan, a Ph.D. student at the University of Washington Allen School of Computer Science & Engineering. The result demonstrates feasibility for a wearable system under controlled conditions; it does not establish that an implant can safely recognize and reverse a real-world overdose.
Implant, wearable, spray and monitor compared
| Option | Detection and delivery | Evidence reported | Bystander needed to trigger dose? | Status and availability | Battery, replacement and alerts |
|---|---|---|---|---|---|
| MIT/Brigham and Women’s Hospital implant | Autonomous multisensor detection; subcutaneous micropump; reservoir up to 10 mg; release in about 10 seconds | Animal overdose experiments; no completed human trial reported | No for the automatic trigger, although emergency help remains necessary | Investigational prototype; not approved or sold | Miniaturization, battery life, implantation location and long-term replacement are unresolved; no external-alert function is described |
| Naloximeter | Optical sensing, implanted naloxone delivery and communications | Rescue reported in small- and large-animal studies | No for automatic administration in the concept | Clinically translatable research platform; not an approved commercial implant | Designed to communicate with first responders; battery and replacement details are not stated |
| University of Washington wearable injector | External wearable algorithm detects stopped breathing and injects naloxone | Breathing data from 25 people with opioid-use disorder; injection demonstrated in 20 healthy volunteers simulating 15-second apnea; no real overdose injection trial reported | The device is intended to trigger automatically, but emergency response is still needed | Experimental wearable, not the MIT implant and not a consumer treatment | Longer unsupervised studies and testing in nonmedical opioid use were still needed; other service-life details are not stated |
| FDA-authorized nonprescription naloxone nasal spray | No automatic detection; naloxone delivered through the nose | FDA-authorized product category; a person must recognize the emergency and administer it according to the label | Yes | Available directly to consumers in the United States | It has no implant battery, sensor or automatic alert function |
| Masimo SafetyNet Opioid System | Monitors physiological markers for opioid-induced respiratory depression and can notify contacts or trigger an emergency-service wellness call; it does not pump naloxone | FDA marketing authorization for a monitored clinical system | People or services respond to the alert | Authorized monitoring system, not an autonomous implanted naloxone device | Provides notification capability; implant duration, reservoir and replacement issues do not apply |
Is this the same as Narcan?
No. Narcan is a brand of naloxone, commonly supplied as a nasal spray. The implant concepts use the same overdose-reversal medicine but change how it is delivered: sensors and a pump would administer naloxone without waiting for someone to find the person and spray a dose. An implant would therefore be a delivery and detection system, not a new antidote.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Best Value
- Ridiculously Fast Relief: Unblock your nose in seconds with Afrin No Drip Severe Congestion Nose Spray Decongestant, a fast-acting sinus spray providing sinus pressure and congestion relief with cooling menthol in a convenient twin pack nasal spray bottle
- Effective for Severe Nasal Congestion: This maximum strength nasal spray decongestant is perfect for relieving severe nasal congestion and sinus pressure caused by colds and allergies, offering quick and effective decongestants for adults and children 6 years and older
- No Drip Technology: Afrin's No Drip sinus medicine ensures the medicated mist stays where it's sprayed, providing effective nasal decongestion without the mess or discomfort of it dripping from your nose or down your throat
- Cooling Menthol Formula: Experience the soothing and cooling sensation of menthol while the powerful nasal decongestant works to constrict blood vessels in the nasal passages and reduce swelling to help you breathe easier
- 12-Hour Non-Drowsy Decongestion: Experience long-lasting relief for up to 12 hours without drowsiness, perfect for both day and night use to alleviate nasal congestion and provide sinus pressure relief
Can you buy or get the implant now?
No. The MIT device and Naloximeter remain investigational. There is no established patient-ordering process, consumer price, implantation service, approved replacement interval or launch date for either platform.
For immediate preparedness, FDA-authorized nonprescription naloxone nasal sprays are the physical product available directly to consumers in the United States. They require a person to recognize a suspected overdose, administer the product according to its approved labeling and contact emergency services. The Masimo SafetyNet Opioid System offers a different current pathway—physiological monitoring and alerts—but it is not an implanted naloxone pump.
What would have to happen before an implant becomes routine care?
- Human trials: Investigators would need to show reliable detection and safe naloxone dosing during actual opioid exposure, not only animal experiments or simulated apnea.
- Long-term implant testing: Studies would need to establish infection risk, tissue compatibility, battery life, reservoir replacement and what happens when the device reaches the end of its service life.
- Specificity testing: Developers would need to quantify false alarms during sleep apnea, illness, exercise and other conditions that alter breathing or vital signs.
- Regulatory review: FDA evaluation would have to cover the sensing algorithm, pump, drug reservoir, communications and surgical procedure as an integrated system.
- Emergency integration: Protocols would need to ensure that an automatic dose is followed by monitoring and professional care, because naloxone can wear off while opioids remain active.
FDA continues to issue guidance for clinical studies of devices intended to treat opioid use disorder, so regulatory evaluation of technologies in this area is ongoing. Until a device completes that process, an investigational implant should not be treated as a substitute for approved naloxone, emergency services or evidence-based addiction care.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
